Brief: Wntresearch Provides Update About Ongoing Phase 2-Study

Opsy Holding AB

26/09/2019 15:49

Sept 26 (Reuters) - Wntresearch AB  WNT.TE :
    * PROVIDES UPDATE ABOUT ONGOING PHASE 2-STUDY
    * TREATMENT WITH FOXY-5 IS WELL TOLERATED WITH VERY FEW SIDE
EFFECTS, NONE OF WHICH ARE SERIOUS

Source text for Eikon:  ID:nWkr1RdZRs 
Further company coverage:  WNT.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))